Last reviewed · How we verify
Thiamin deficiency — Treatment Landscape & Competitive Intelligence
2 marketed
0 Phase 3
0 Phase 2
Live · 30-min refresh
Marketed treatment landscape
| Drug | Generic | Sponsor | Class | Target | Line of therapy | First approval |
|---|---|---|---|---|---|---|
| Thiamine Hydrochloride | THIAMINE | Pfizer | thiamine (vit B1) | Heat shock protein HSP 90-alpha | 1993-01-01 | |
| Thiamin | Thiamin | Hospital Sao Domingos | Thiamin pyrophosphokinase 1, Thiamine transporter 1, Thiamine-triphosphatase |
Phase 3 pipeline
Phase 2 pipeline
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Sponsor landscape
- Hospital Sao Domingos · 1 drug in Thiamin deficiency
- Pfizer · 1 drug in Thiamin deficiency
Subscribe to ongoing alerts
Every new regulatory action, PDUFA date, or trial completion in Thiamin deficiency:
- Thiamin deficiency treatment updates — RSS
- Thiamin deficiency treatment updates — Atom
- Thiamin deficiency treatment updates — JSON
Cite this brief
Drug Landscape (2026). Thiamin deficiency — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/thiamin-deficiency. Accessed 2026-06-10.
Related
- Thiamin deficiency full disease profile — treatment pathway, diagnostics, guidelines
- Browse all CI briefs
- Build a custom feed
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing